Introduction: Focused extracorporeal shockwave
INTRODUCTION
Cellulite is a widespread problem involving the buttocks and thighs of the female-specific anatomy [1] . The higher number of fat cells stored in female fatty tissue in contrast to males, the gender-specific dimorphism with subdermal septae orientated orthogonally toward the skin, and the aging process of connective tissue lead to an imbalance between lipogenesis and lipolysis with subsequent large fat cells bulging the skin [1] . Recently, a case-control study in 15 lean women suffering from cellulite, and ageand body mass index (BMI)-matched controls identified significantly reduced adiponectin expression using reverse transcription polymerase chain reaction among the celluliteaffected patients [2] . Cellulite appears to potentially impair quality of life of affected females substantially. It appears that younger females affected by cellulite suffer more in terms of impaired quality of life than more mature females [3] .
Non-randomized clinical data suggest that extracorporeal shock wave therapy (ESWT) is beneficial in terms of improved skin elasticity and revitalizing dermis in females with cellulite [4, 5] . Potentially, a direct effect on the associated lymphedema is a further potential consequence of ESWT application in cellulite. A recent Korean prospective clinical trial evaluated the effect of four ESWT sessions (0.056-0.068 mJ/mm 2 , 2,000 impulses, ESWT device from Dornier AB2) within 2 weeks in patients suffering from secondary lymphedema [6] . Both the circumference and the thickness of the skin fold of the affected region were significantly reduced by as much as 37% in line with a pain reduction on the visual analogue scale [6] . In systemic sclerosis, ESWT is able to again improve pain and the Rodnan skin score for skin wellness [7] .
To date, a limited number of non-controlled studies (two Level III [4, 8] and two Level IV studies [9, 10] ) examined the effect of ESWT on cellulite with various outcome measures (Table 1) .
Recently, a small size (n = 25) randomizedcontrolled trial (RCT) with large confidence intervals (CIs) has been published (level 2 evidence) [11] . The 
METHODS
The study protocol was composed according to the most recent CONSORT 2010 recommendations for transparent reporting of RCTs [12, 13] . The study protocol according to the CONSORT recommendations has been published previously [14] .
Ethics and Trial Registration
This RCT was approved in all patients for being included in the study and for the publication of patient photographs.
Study Design
This was a single-center, double-blinded, RCT with a 1:1 parallel group randomization.
Participants
The mean age of the enrolled participants was Fig. 1 .
Interventions
In CelluShock-2009 patients were randomly assigned with a 1:1 ratio to either ESWT with compliance, respectively.
Primary and Secondary Outcome Measures
The primary endpoint, with respect to efficacy of the combined ESWT and gluteal strength exercises versus SHAM-ESWT and the same gluteal strength exercise program, was the change on digital photographs 3 months after the last ESWT treatment assessed by the validated CSS [15] . This provided reliable, comprehensive, and reproducible results.
Cellulite severity may be classified according to the result of this assessment in the CSS in three degrees, as described in Table 2 .
The classification was performed based on standardized photographs taken by a professional medical photographer at baseline and 12 weeks after the last ESWT treatment in both groups. The assessment of the anonymous digital images was carried out by two blinded assessors who were not aware of either the study arm or the fact that it is a baseline or a follow-up photograph taken 12 weeks after the last ESWT treatment in both groups. In order to overcome the problems of interpretation associated with multiplicity of analyses we decided to choose the aforementioned clinical endpoint which is a visual one as the primary endpoint and results as secondary endpoints in CelluShock.
Secondary endpoints of the CelluShock RCT were as follows: change of circumference of the thigh (cm), skin elasticity using the Cutometer Ò (Cutometer MPA 580, Kosmetik Konzept KOKO GmbH & Co KG, Leichlingen, Germany) [16] [17] [18] [19] , and self-assessment of the success on a visual analogue scale 0-10 (0 = no change, 10 = fully satisfied).
All patients were measured at baseline and after 12 weeks regarding the primary and all secondary endpoints.
Power Calculation
To detect at least a change of two points in the CSS of cellulite, with a two-sided, 5% significance with an 80% power, a sample size of 26 participants with an estimated drop-out rate of 15% was calculated. This was done prior to the start of trial. 
Randomization and Allocation Sequence
For allocation of participants, a 1:1 ratio randomization was performed using opaque envelopes for the concealment of allocation.
The allocation sequence was concealed from the researcher (BJ) enrolling and assessing participants in sequentially numbered, opaque, sealed envelopes [20] .
Blinding
Blinding was achieved for all participants enrolled in the trial, the photographer taking the digital images for the primary outcome measure, the two assessors of the outcome measures, all additional health care providers, and for the analyst from the biometrical department. Only one researcher (BJ) was aware of the group assignment performing the randomization and the ESWT. The assessment of the primary and secondary outcomes was performed by blinded assessors independently from each other, unaware whether the digital image displayed was before or after therapy or with group (intervention or control group) was randomized.
Statistical Analysis
The primary endpoint was change of CSS assessed on digital, standardized photographs by two independent expert examiners.
Student's t test was applied for parametric data, the Wilcoxon test for non-parametric data, and a level of P\0.05 was reported as
significant. An intention-to-treat analysis was applied. SPSS (IBM Corp., New York, USA) was used to carry out the analysis. Figure 1 highlights the patient flow throughout the CelluShock-2009 RCT (Fig. 1) .
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RESULTS
Primary Outcome Measure-Cellulite
Severity Scale
The CSS (mean ± SE) in the intervention group was 10.9 ± 3.8 before and 8.3 ± 4.1 after the combined ESWT and strength exercise Table 3 ). The CSS in the control group was 10.0 ± 3.8 before and 10.1 ± 3.8 after the SHAM-ESWT and strength exercise intervention (P = 0.876, 95% CI -1.1 to 0.97).
The change of the CSS in the intervention group versus the control group was significantly different (P = 0.001, -24.3 effect size, 95% -36.5 to -12.1).
The results for the five items of the CSS, the cutometer data, and the thigh circumferences are reported below; all values are given as mean ± SE unless otherwise stated.
Number of Depressions
The number of depressions in the intervention group was 2.2 ± 0.8 at baseline and 1.8 ± 0.9 at follow-up (P = 
Depth of Depressions
The depth of depressions in the intervention group was 2.2 ± 0.8 at baseline and 1.6 ± 0.8 at 
Morphological Appearance of Skin Surface Alterations
The morphological appearance of skin surface alterations in the intervention group was 2.2 ± 0.8 at baseline and 1.6 ± 0.8 at follow-up (P = 0.001, 0.6 improvement, 95% 0.36-0.8).
The morphological appearance of skin surface alterations in the control group was 1.9 ± 0.8 at baseline and 1.9 ± 0.6 at follow-up (P = 0.837, 95% CI -0.20 to 0.25). The change of the morphological appearance of skin surface alterations in the intervention group versus the control group was significantly different (P = 0.007, -16.6 effect size, 95% CI -28.7 to -4.6).
Grade of Laxity, Flaccidity or Sagging Skin
The grade of laxity, flaccidity or sagging skin in the intervention group was 2.2 ± 0.8 at baseline and 1.6 ± 0.8 at follow-up (P = 0.001, 0.5 improvement, 95% CI 0.27-0.73). The grade of laxity, flaccidity or sagging skin in the control group was 2.0 ± 0.9 at baseline and 2.1 ± 0.8 at follow-up (P = 0.516, 95% CI -0.34 to 0.17).
The change of the grade of laxity, flaccidity or sagging skin in the intervention group versus the control group was significantly different (P = 0.001, -25.1 effect size, 95% CI -39.6 to -10.6).
Classification Scale by Nürnberger and Müller
The classification scale by Nürnberger and
Müller in the intervention group was 2.2 ± 0.8 at baseline and 1.8 ± 0.9 at follow-up effect size, 95% CI -37.7 to -11.1).
Change of Circumference of the Thigh and Body Mass Index
The change of thigh circumference in the intervention group was 61.5 ± 6.2 cm at baseline to 61.0 ± 5.9 cm at follow-up (P = 0.760, 95% CI -2.91 to 3.97). There was no change of thigh circumference in the control group (61.6 ± 6.9 cm) at baseline versus followup (61.6 ± 6.9 cm; P = 0.996; 95% CI -4.28 to 4.31). Pre-and post-treatment body weight index did not change in either group significantly beyond 3%.
Skin Elasticity Using the Cutometer
Ò
The skin elasticity in the intervention group was 14.1 ± 2.5% at baseline and 14.1% ± 1.6 at follow-up (P = 0.963; 95% CI -1.22 to 1.16).
The skin elasticity in the control group was 14.4% ± 1.8 at baseline and 14.1% ± 1.9 at follow-up (P = 0.676; 95% CI -0.91 to 1.38).
DISCUSSION
The combination of focused ESWT (0.35 mJ/ mm 2 , 2,000 impulses, 6 sessions) in combination with gluteal strength training was superior to a gluteal strength training alone in terms of the CSS in a 3-month perspective. The significant mean improvement was 24% in the intervention group in contrast to the control group, a clinically meaningful difference. Second, the SHAM-ESWT and the gluteal strength training were not able to change the CSS.
The strengths of this double-blinded, randomized clinical trial are the independent assessment by two expert examiners who were blinded to both the patients and the group allocation. Both experts assessed the digitalized standardized photographs independently and the mean of both assessments was applied. Second, this is the first registered, double-blinded, However, to date we cannot estimate the long-term efficacy and sustainability of the aforementioned clinical effects in a perspective of one or more years. It is possible that, after a year, an additional treatment might be warranted, such as a touch-up procedure. In our personal experience, select cases might benefit even longer than 1 year from a set of six focused shockwave sessions, but this is only a non-controlled observation.
The results of this randomized clinical study should be discussed in detail. The CSS is a validated photo-numeric Cellulite Severity Scale, which has been published in 2009 by Dr. Hexsel and coworkers [15] . Beyond the wellknown Nürnberger and Müller score ranging from 0°to 3°, this validated score appears to better reflect even modest to small changes of a given therapeutic intervention. The CSS has a high intraclass correlation coefficient of 0.9 or more and ranges from 1 to 15. Three clinical cellulite severity grades have been proposed by Hexsel et al. [15] (Table 2) . Given our patients, we included the majority of patients with moderate to severe degrees of cellulite. This is partially reflected by the mean age beyond 40 years and the BMI beyond 24.2 kg/m 2 in both groups.
As far as the underlying mechanisms of the evident improvements in the CSS are concerned, a ''mechanical'' response might be evident as well as a ''regenerative'' response of the afflicted skin.
In terms of the ''mechanical'' perspective, one might speculate that the focused extracorporeal shockwave has somewhat disrupted either the fat components or the septae or both, which might lead to a smoothening of the afflicted skin. MR imaging has shown that fibrous septa are visualized in 97% of the area with cellulite depressions, which are markedly thickened in cellulite afflicted areas [21] . Shockwave energy might have weakened the fibrous septae and thus the afflicted skin became smoother.
Reduction of lymphedema is a second potential underlying mechanism. Recently, a significant reduction of lymphedema was reported clinically following four ESWT sessions in females with secondary lymphedema following breast cancer treatment [6] . In animal experiments ESWT and the vascular endothelial growth factor (VEGF-C) hydrogel appear to exert a synergistic effect in promoting lymphangiogenesis [22] .
On the other hand, ESWT might somewhat influence mesenchymal stem cells. There is evolving experimental data suggesting that shockwave therapy activation pathways in adipose-derived stem cells [23] . Clinically, diseased skin appears to normalize following shockwave treatment such as in progressive systemic sclerosis with an up regulation of endothelial progenitor cells and circulating endothelial cells [24] .
Energy flux density of the focused ESWT is another issue to concern. We used low to medium energy flux densities of 0.35 mJ/mm 2 with 1,000 impulses on each thigh with 4 Hz.
To date, we do not know in controlled trials whether potentially higher energy flux densities such as up to 1.24 mJ/mm 2 might be even more beneficial in terms of the potential disruption of the fibrous septae in the cellulite-afflicted areas.
On the other hand, stem-cell activation might be achieved by rather low-energy flux densities in regard of the aforementioned potential underlying ''regenerative'' mechanisms.
To date, only small size, controlled trials with wide CIs have been published [7, 25] . We tried to overcome the methodological shortcomings of previous trials in CelluShock-2009. In regard to different techniques, there are evolving clinical data that, for example, lowlevel laser therapy with 532 nm wave lengths appears to improve cellulite in a double-blind, placebo-controlled, randomized trial [26] .
1,064 nm Nd:YAG laser appears to improve mild to moderate cellulite also [27] .
Radiofrequency is able to reduce cellulite in a randomized trial [28] .
Limitations
Given our randomized, 
